Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2011 | 12-2010 | 06-2010 | 12-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,360 | N/A | -4,320 | N/A | -5,620 |
| Depreciation Amortization | 30 | N/A | 30 | N/A | 20 |
| Other Working Capital | 1,520 | N/A | -500 | N/A | -10 |
| Other Operating Activity | 310 | 0 | 640 | 0 | 380 |
| Operating Cash Flow | $-4,500 | $N/A | $-4,150 | $N/A | $-5,230 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | N/A | -20 | N/A | -20 |
| Investing Cash Flow | $-10 | $N/A | $-20 | $N/A | $-20 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 8,240 | 0 | 4,980 | 0 | 70 |
| Financing Cash Flow | $8,240 | $N/A | $4,980 | $N/A | $70 |
| Exchange Rate Effect | -140 | N/A | -2 | N/A | 10 |
| Beginning Cash Position | 5,170 | N/A | 3,790 | N/A | 8,390 |
| End Cash Position | 8,740 | N/A | 4,610 | N/A | 3,220 |
| Net Cash Flow | $3,570 | $N/A | $810 | $N/A | $-5,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,500 | N/A | -4,150 | N/A | -5,230 |
| Free Cash Flow | -4,500 | 0 | -4,150 | 0 | -5,230 |